Originally developed to treat people with type-2 diabetes (T2DM), these drugs have proven useful for addressing a range of other conditions, from obesity to sleep apnea
Support the Signals That Shape Your Weight* Akkermansia muciniphila and clinically studied postbiotic BPL1 come together for the first time in this unique probiotic + postbiotic formula to deliver targeted support to the gutmetabolic connection for healthy weight management.* Akkermansia aids your bodys natural GLP-1 production, while clinically studied postbiotic BPL1 helps reduce abdominal fat and support healthy blood sugar metabolism.* Designed to Survive Each capsule delivers 500 million AFUs live Akkermansia muciniphila and delays release for survivability through stomach acid
Rybelsus saving card: Pay as little as $10 for a 1-month, 2-month, or 3-month supply if enrolled in commercial insurance with coverage for Rybelsus
Zepbound Lawsuit 2026 Update July 1, 2026: Over 80 Lawsuits About Zepbound, Similar GLP-1 Drugs Join the MDL The consolidated multidistrict litigation about Zepbound and other GLP-1 products has grown to include 3,848 lawsuits as of July 1, 2026
This mini review delves into key chromatin modifiers, including the histone methyl transferases NSD1 and ASH1L, the methyl-CpG-binding repressor MeCP2, and the enzymatic repressor EZH2